Albiglutide does not impair the counter-regulatory hormone response to hypoglycaemia: a randomized, double-blind, placebo-controlled, stepped glucose clamp study in subjects with type 2

Article Authors: M Hompesch, A Jones-Leone, M C Carr, J Matthews, H Zhi, M Young, L Morrow, R R Reinhardt


To determine if the glucagon-like peptide-1 (GLP-1) receptor agonist albiglutide, once weekly, impairs counter-regulatory responses during hypoglycaemia.